Skip to main content
. Author manuscript; available in PMC: 2008 Apr 11.
Published in final edited form as: J Invest Dermatol. 2007 May 24;127(10):2469–2471. doi: 10.1038/sj.jid.5700903

Table I.

Descriptions and β-gal staining patterns of nevi examined.

# Age Sex Site Diagnosis β-gal pH 4 β-gal pH 5 β-gal pH 6
1 48 F chest CMN, congenital and dysplastic features 1+ nd neg
2 48 M arm IDN, congenital features 2+ 1+ neg
3 29 M back CMN, congenital and dysplastic features 1+ 1+ neg
4 27 F back Dysplastic nevus, mild atypia 1+ neg neg
5 48 F groin CMN 3+ 1+ neg
6 36 M back lower CMN, congenital and dysplastic features 2+ neg neg
7 61 F leg IDN, congenital features 3+ 2+ neg
8 23 M back CMN, congenital and dysplastic features 2+ 1+ neg
9 33 F back CMN, congenital features 3+ 2+ neg
10 23 F groin CMN 1+ neg neg
11 44 F hand CMN, congenital features 3+ 3+ neg
12 73 F chin IDN 1+ 1+ neg
13 28 M back upper CMN, congenital features 2+ 2+ neg
14 34 F arm Blue nevus focal/1+ neg neg
15 30 F shoulder Dysplastic nevus, moderate atypia 1+ neg neg
16 56 F back IDN 1+ 1+ neg
17 57 M back IDN 2+ 2+ neg

CMN, compound melanocytic nevus; IDN, intradermal melanocytic nevus.

Scoring: neg, negative staining; 1+, <25% cells positive; 2+, 25–75% cells positive; 3+, 75–100% cells positive; nd, not done.